Stock Research: Ono Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Ono Pharmaceutical

TSE:4528 JP3197600004
90
  • Value
    80
  • Growth
    74
  • Safety
    Safety
    63
  • Combined
    94
  • Sentiment
    53
  • 360° View
    360° View
    90
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company that manufactures and sells pharmaceuticals. The company operates in the pharmaceutical industry. ONO PHARMACEUTICAL CO., LTD. operates primarily in Japan. In the last fiscal year, the company had a market cap of $5,561 million, profits of $2,260 million, revenue of $3,247 million, and 4287 employees.

more
Index
TOPIX 100
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
80 94 84 65
Growth
74 22 11 57
Safety
Safety
63 95 90 82
Sentiment
53 6 32 31
360° View
360° View
90 61 55 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
3 1 5 41
Opinions Change
63 35 50 40
Pro Holdings
n/a 10 70 82
Market Pulse
62 46 44 12
Sentiment
53 6 32 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
80 94 84 65
Growth
74 22 11 57
Safety Safety
63 95 90 82
Combined
94 89 75 82
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
76 88 100 89
Price vs. Earnings (P/E)
43 69 41 39
Price vs. Book (P/B)
69 88 62 61
Dividend Yield
86 91 89 77
Value
80 94 84 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
4 41 10 76
Profit Growth
73 4 54 52
Capital Growth
86 79 32 17
Stock Returns
88 8 19 55
Growth
74 22 11 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
53 83 85 80
Refinancing
52 73 51 39
Liquidity
70 97 98 96
Safety Safety
63 95 90 82

Similar Stocks

Discover high‑ranked alternatives to Ono Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Alfresa Holdings

TSE:2784
Country: Japan
Industry: Health Care Distributors
Size: Large
Full Stock Analysis

Starts

TSE:8850
Country: Japan
Industry: Real Estate: Diversified Operations
Size: Medium
Full Stock Analysis

Kyudenko

TSE:1959
Country: Japan
Industry: Construction & Engineering
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is an all-around strong stock. It shows good value, high growth, safe financing, and positive professional sentiment. It is ideal for most buy-and-hold investors who value a good all-around stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: